Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
CHICAGO, Feb. 20, 2018 -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of Scott A. Falk, MD, to the firm’s Physician Advisory Council.
A practicing anesthesiologist and critical care physician, Dr. Falk serves as Director of Performance Improvement, Quality and Safety at Penn Medicine (University of Pennsylvania). He is also an Associate Professor of Clinical Anesthesiology and Critical Care at the University of Pennsylvania. He brings a wealth of experience, including past positions as post-anesthesia care unit (PACU) and surgical intensive care unit (SICU) medical director, and years of experience improving healthcare value and outcomes.
“Our Physician Advisory Council uniquely enables us to foster alignment between physicians and hospital leaders with insights from practicing clinicians,” said Lumere CEO Hani Elias, JD, MPH. “With Dr. Falk’s background, we’re now able to provide even more in-depth guidance to our clients as they tackle issues related to device and drug selection for anesthesiology and critical care, two areas that offer significant opportunities.”
According to Dr. Falk, he’s eager to help Lumere’s clients optimize patient care. “Healthcare costs have been spiraling out of control for a number of years, partly due to the vast array of devices and therapies we have to choose from,” he said. “However, the reality is that patient outcomes have not improved at the same pace. Lumere allows physicians to work with their hospitals to refocus on providing the right solutions and making the best decisions about patient care.”
Dr. Falk joined the faculty of Penn Medicine in 2006. He received his medical degree from The George Washington University School of Medicine and Health Sciences and completed his fellowship with the Clinical Clinic Foundation.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260
